Help | Sitemap | Archive | Advanced Search | Mirror in USA   
  CHINA
  BUSINESS
  OPINION
  WORLD
  SCI-EDU
  SPORTS
  LIFE
  WAP SERVICE
  FEATURES
  PHOTO GALLERY
 Globalization Forum

Message Board
Feedback
Voice of Readers
China Quiz
 China At a Glance
 Constitution of the PRC
 State Organs of the PRC
 CPC and State Leaders
 Chinese President Jiang Zemin
 White Papers of Chinese Government
 Selected Works of Deng Xiaoping
 English Websites in China
Help
About Us
SiteMap
Employment

U.S. Mirror
Japan Mirror
Tech-Net Mirror
Edu-Net Mirror
 
Saturday, December 09, 2000, updated at 17:33(GMT+8)
Sci-Edu  

China, US Form Gene Research Joint Venture

Cellgene, a biotechnology Sino- US joint venture, was formed Friday in Pudong, Shanghai, China's industrial and business center, to focus on gene research associated with treating disease.

The company was jointly formed by the Shanghai Pharmaceutical (Group) Corp. and the US-based Kanda Natural Medicine Research Center (KNMRC), with a total investment of 100 million yuan.

Cellgene is expected to discover two or three individual genes, vital for treating cancer and heart disease, during the next two to three years with the efforts of Chinese and US experts, said James B. Ding, president of KNMRC.

Experts in Shanghai noted that the cooperation project will greatly improve the innovation capacity of the city's biotechnology sector and will also help create opportunities for the pharmaceutical industry.

According to Ding, biotechnology firms worldwide are now in a race to discover individual genes, which are considered the key to developing medicines.

The KNMRC, based in San Diego, California in the United States, has developed a number of new technologies for genetic cloning and genetic expression since it was founded in 1993.







In This Section
 

Cellgene, a biotechnology Sino- US joint venture, was formed Friday in Pudong, Shanghai, China's industrial and business center, to focus on gene research associated with treating disease.

Advanced Search


 


 


Copyright by People's Daily Online, all rights reserved